I like ABBVIE but its little overpriced right now, considering how much Debt they accumulated on acquisitions that didn't realize or the drugs never worked. But they are coming out with new cancer products, that could replace the income which will be lost from HUMIRA in the next 2 years. I would go long at lower prices. For now shorting ABBVIE untill it hits $68...